Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
about
Ustekinumab in psoriasis immunopathology with emphasis on the Th17-IL23 axis: a primerUstekinumabBurden of Moderate-to-Severe Plaque Psoriasis and New Therapeutic Approaches (Secukinumab): An Italian PerspectiveManaging Patients With Psoriasis in the Busy Clinic: Practical Tips for Health Care PractitionersNew and emerging biologic therapies for moderate-to-severe plaque psoriasis: mechanistic rationales and recent clinical data for IL-17 and IL-23 inhibitorsTumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature reviewActivated protein C: A regulator of human skin epidermal keratinocyte functionNuclear hormone receptor functions in keratinocyte and melanocyte homeostasis, epidermal carcinogenesis and melanomagenesisNew era of biologic therapeutics in atopic dermatitisA multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis.Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasisManagement of psoriasis patients with hepatitis B or hepatitis C virus infectionPsoriasis: classical and emerging comorbiditiesPsoriasis and comorbid diseases: Implications for management.Subclinical enthesopathy in patients with psoriasis and its association with other disease parameters: a power Doppler ultrasonographic studyBiologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring.Safety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open-label extension trial of the interleukin-12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasis.Rationale and early clinical data on IL-17 blockade in psoriasis.Under-Treatment of Patients with Moderate to Severe Psoriasis in the United States: Analysis of Medication Usage with Health Plan DataDiagnosis and management of psoriasis.Diagnostic et prise en charge du psoriasisThe Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives.Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study.Evaluating Dosage Optimality for Tofacitinib, an Oral Janus Kinase Inhibitor, in Plaque Psoriasis, and the Influence of Body WeightPatient considerations and targeted therapies in the management of psoriasis in Chinese patients: role of ustekinumab.Psoriasis, Psoriatic Arthritis, and Thyroid AutoimmunityRecent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: just the tip of the iceberg?Psoriasis, anti-tumor necrosis factor therapy, and tuberculosis: report of three challenging cases and literature review.Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasisIs There a Potential Role for Anti-tumor Necrosis Factor Therapy in Patients with Human Immunodeficiency Virus?The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities.Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents.A Practical Approach to Home UVB Phototherapy for the Treatment of Generalized Psoriasis.A practical approach to monitoring patients on biological agents for the treatment of psoriasisTreatment patterns in psoriatic arthritis patients newly initiated on oral nonbiologic or biologic disease-modifying antirheumatic drugs.Value of entheseal ultrasonography and serum cartilage oligomeric matrix protein in the preclinical diagnosis of psoriatic arthritis.The 5-point Investigator's Global Assessment (IGA) Scale: A modified tool for evaluating plaque psoriasis severity in clinical trials.The burden of psoriatic arthritis: a literature review from a global health systems perspective.Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.Chinese medicine combined with calcipotriol betamethasone and calcipotriol ointment for Psoriasis vulgaris (CMCBCOP): study protocol for a randomized controlled trial.
P2860
Q24596756-BFFE723F-CCE2-4C74-8D2C-3CB66BA53F22Q24651927-65846BBF-92AF-475F-A6ED-4CADBD50A38CQ26747639-618B199E-67DE-4FC9-B807-98B087566909Q26771785-69EB6E8A-D512-41D2-A972-D385BA764173Q26800937-7CD6EF66-9B8A-429D-B532-9356C79D27D4Q26829390-0DADCA8C-D883-4B18-9561-1D8D90100860Q26830499-10C730F3-C830-42A7-A177-6524BA5A0A01Q26859617-8622FE8F-1BAF-48A1-B1CF-713F2A106E17Q27001941-9E69ABE7-2223-449F-8D5A-844B9903EF1FQ27334725-2A609596-964F-47FA-B145-997C5321766CQ27693878-0DCFDAB5-B81A-4508-8463-241134D3B1B5Q28078157-7CC61EDC-BA1B-4F1D-90E0-25AF2B7A89CCQ28088340-FAAAC62D-4B18-4AA4-B170-25F1C39188F7Q30235888-B08D4858-E093-4754-8979-7F051474C064Q30361133-7EFAA573-6A2D-4DB7-9C46-08006F177ADAQ30412650-73D16209-FC38-4484-BF1B-F2A0F809C160Q30577671-39C81254-F87E-4DB2-A6C8-C56078B94788Q30658185-533B4789-6CF3-4D9F-8835-87121CD2BBCFQ31146263-458B1A34-DDFB-48D4-B442-8CB95161A1CAQ33558495-54E27D12-1DB5-465D-B715-E0BDDE004E52Q33558550-09CBD6D4-3E7C-4F4F-99B1-F3C3587BE552Q33572834-FF196639-AF3B-4C27-893C-5C0CF2179F4BQ33650112-A451D5C7-C1EC-4A96-9E2A-DFD8BB27F33FQ33729774-85961315-EA5F-4DA7-880A-C501482722B1Q33800651-0996F9B6-D5BB-4D5D-8BB4-689E98720B79Q33809992-6BCA1671-BC17-4C95-9539-4FF32DF14CC8Q33872389-050CE815-0CFB-42D8-AFD5-0C12791B5F1EQ33939033-C0743C5D-BA5C-4A43-80E3-527B4404F8BDQ34041797-85AC12E2-4B22-4513-93D7-091DA8EF9CF4Q34074149-FB62BBAB-8992-4954-8BEA-B92B5665B96CQ34076431-2F64CED1-77A3-40EA-AE3D-A498C1A3B536Q34112840-BC64A865-848F-4BB1-97A1-95ABB917E9E3Q34117369-4C8B243E-356E-4238-92CD-90EDA671AFBDQ34156420-5D6C279C-AC40-4A6E-9302-0F4D33CF17C6Q34267352-4E8ED1E8-80F1-4717-ABD5-A90A902478F1Q34340028-B4B9F97D-CF6A-4AF6-A8EF-BC8DE97368D9Q34393068-A6D375F5-E732-4874-8697-7C7A67C03445Q34432846-7FEE7D99-A759-4526-9464-CAF173B26167Q34449302-E52EFC4A-53FA-4DF3-BDFC-3B65DFA37140Q34469802-87966B3A-2821-4C25-8918-7D336080B519
P2860
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Guidelines of care for the man ...... t of psoriasis with biologics.
@ast
Guidelines of care for the man ...... t of psoriasis with biologics.
@en
Guidelines of care for the man ...... t of psoriasis with biologics.
@nl
type
label
Guidelines of care for the man ...... t of psoriasis with biologics.
@ast
Guidelines of care for the man ...... t of psoriasis with biologics.
@en
Guidelines of care for the man ...... t of psoriasis with biologics.
@nl
prefLabel
Guidelines of care for the man ...... t of psoriasis with biologics.
@ast
Guidelines of care for the man ...... t of psoriasis with biologics.
@en
Guidelines of care for the man ...... t of psoriasis with biologics.
@nl
P2093
P1476
Guidelines of care for the man ...... t of psoriasis with biologics.
@en
P2093
Abby S Van Voorhees
Alan Menter
Alice Gottlieb
Craig A Elmets
Craig L Leonardi
John Y M Koo
Karl R Beutner
Kenneth B Gordon
Mark Lebwohl
Neil J Korman
P304
P356
10.1016/J.JAAD.2008.02.039
P407
P577
2008-05-01T00:00:00Z